Pfizer vaccine vials after use.
A slowdown that could ultimately be short-lived.
While Europe fears since Friday a delay of "three to four weeks" on deliveries of doses of the Pfizer / BioNTech vaccine, the American group announces this Saturday attempting to limit this period to one week.
"Pfizer and BioNTech have developed a plan that will increase manufacturing capacity in Europe and deliver many more doses in the second quarter," the two companies said in a joint statement.
"We will return to the original schedule of deliveries to the European Union from the week of January 25, with an increase in deliveries from the week of February 15," add the two groups.
“To do this, certain modifications to the production processes are now necessary”.
A bad surprise at the end of the week
The American group Pfizer, associated with the German laboratory BioNTech, had unexpectedly warned this weekend that it was not going to be able, until early February, to provide EU countries with the weekly quantities to which he was committed to fighting the coronavirus pandemic.
Berlin had mentioned a drop in pace "for three to four weeks".
In their latest press release, Pfizer and BioNTech indicate that their plant in Puurs, Belgium, "will experience a temporary reduction in the number of doses delivered in the coming week".
Coronavirus: Joe Biden plans to open "thousands" of nearby vaccination centers
Coronavirus: 21,271 new contaminations in the last 24 hours